Boston Scientific, Cordis Seek New Trial In Stent Case
Less than two weeks after a federal court jury held Boston Scientific Corp. liable for infringing on Cordis Corp.'s stent patents, both companies have agreed that the court failed to resolve...To view the full article, register now.
Already a subscriber? Click here to view full article